Search - tctmd.com

Displaying 61 - 80 of 169

Sort: Relevancy | Date

Presentation THT 2023

Update on the Phase 2 REBALANCE-HF Trial of SAVM for HFpEF/HFmrEF: Lessons Learned and Future Directions

Presenter: Sanjiv Shah

March 21, 2023

Presentation THT 2023

Mechanistic Overview of SAVM: Splanchnic Ablation for Volume Management in Heart Failure Patients

Presenter: Marat Fudim

March 21, 2023

Presentation THT 2023

Current Treatment Landscape for HFpEF: Is there still an unmet need?

Presenter: Sheldon Litwin

March 21, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Daily News

Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM

Todd Neale

September 15, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

Presentation THT 2022

Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Overview of the physiology of the splanchnic bed in HFpEF and HFrEF

Presenter: Marat Fudim

February 01, 2022

Presentation TCT 2021

TCT 713: A Case Of Septal Reduction With Tru-Septal RF Ablation Via Coronary Sinus (TIRA) In HOCM Patient: Representative Case of The First in Man Trial Of TIRA

Presenter: Min-Ku Chon

November 04, 2021

Advertisement

Update on the Phase 2 REBALANCE-HF Trial of SAVM for HFpEF/HFmrEF: Lessons Learned and Future Directions

Mechanistic Overview of SAVM: Splanchnic Ablation for Volume Management in Heart Failure Patients

Current Treatment Landscape for HFpEF: Is there still an unmet need?

What’s Going to Be Hot at ACC/WCC 2023?

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF

Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF

Overview of the physiology of the splanchnic bed in HFpEF and HFrEF

TCT 713: A Case Of Septal Reduction With Tru-Septal RF Ablation Via Coronary Sinus (TIRA) In HOCM Patient: Representative Case of The First in Man Trial Of TIRA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content